IP Verse

Alfasigma S.p.a. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Alfasigma S.p.a.

Patent Number:
EP3536311
Title:
Storage Stable Composition Comprising Rifaximin Alpha
Applicant:
SANDOZ AG
Opposition Date:
Sep 22, 2022
Patent Number:
EP3434265
Title:
Pharmaceutical Composition Containing Rifaximin Alpha & Delta
Applicant:
SANDOZ AG
Opposition Date:
Mar 21, 2022
Patent Number:
EP3416627
Title:
Oral Dosage Form Comprising Rifaximin In Form Beta
Applicant:
SANDOZ AG
Opposition Date:
Aug 27, 2020
Patent Number:
EP3373914
Title:
Storage Stable Composition Comprising Rifaximin Alpha
Applicant:
SANDOZ AG
Opposition Date:
Jan 24, 2020
Patent Number:
EP3294270
Title:
Pharmaceutical Composition Containing Rifaximin Alpha&Delta
Applicant:
SANDOZ AG
Opposition Date:
Jun 12, 2019

Latest patents of Alfasigma S.p.a. opposed by its competitors

Patent:
EP3439637
Grant Date:
Jun 1, 2022
Title:
Process For Mesalazine Solid Formulations
Oppositions:
1
Patent:
EP2618819
Grant Date:
Nov 1, 2017
Title:
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
Oppositions:
1
Patent:
EP2560662
Grant Date:
Jun 7, 2017
Title:
Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved
Oppositions:
2
Patent:
EP2059232
Grant Date:
Apr 19, 2017
Title:
Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin
Oppositions:
3

Competitors of Alfasigma S.p.a.

SANDOZ AG

SANDOZ GMBH

BOTTI & FERRARI S.R.L.

Want to track Alfasigma S.p.a.?

Feel free to send us a message here and we will get back to you